ÓÉÉϺ£ÊÐÏÖ´úÉúÎïÓëÒ½Ò©¹¤Òµ°ì¹«ÊÒÖ÷Àí£¬£¬ £¬£¬ £¬£¬£¬£¬Ñï×Ó½­Ò©Òµ¼¯ÍÅ¡¢ÉϺ£ÊÐÉúÎïÒ½Ò©¿Æ¼¼¹¤ÒµÔö½øÖÐÐÄ¡¢ÉϺ£ÊпƼ¼»áÕ¹ÓÐÏÞ¹«Ë¾³Ð°ìµÄ¡°µÚÊ®Èý½ìÉϺ£¹ú¼ÊÉúÎïÊÖÒÕÓëÒ½Ò©×êÑлáôßÑï×Ó½­Ò©Òµ¼¯ÍÅÉúÎïÖÆ¼Á×êÑлᡱÓÚ6ÔÂ1ÈÕÔÚÉϺ£ÊÐÊÀ²©ÖÐÐľÙÐС£¡£¡£¡£¡£¡£
    ÉϺ£ÊпƼ¼µ³Î¯Êé¼Ç³Â¿Ëºê¡¢ÉϺ£ÊÐʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö¸±¾Ö³¤ÌÆÃñð©Ó¦Ñû³öϯÁË´ó»á²¢ÖºشÇ¡£¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯ÍŶ­Ê³¤¡¢×Ü˾ÀíÐì¾µÈËÔÚÖ´ÇÖÐÌåÏÖ£¬£¬ £¬£¬ £¬£¬£¬£¬ÔÚʵÑéÖÐÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©¡°ÈýÒ©¡±²¢¾ÙµÄÑз¢Õ½ÂÔÖУ¬£¬ £¬£¬ £¬£¬£¬£¬ÒÔºóÑï×Ó½­Ò©Òµ½«°ÑÑз¢µÄÖØµãºÍÖØÐÄÏòÉúÎïÒ©×ªÒÆ£¬£¬ £¬£¬ £¬£¬£¬£¬Ï£Íûͨ¹ýÕâ´Î×êÑлᣬ£¬ £¬£¬ £¬£¬£¬£¬½øÒ»²½ÍØÕ¹ÊÓÒ°£¬£¬ £¬£¬ £¬£¬£¬£¬Ãé×¼¹ú¼ÊÇ°ÑØ£¬£¬ £¬£¬ £¬£¬£¬£¬ÏàʶÉúÎïÒ©×îÐÂÏ£ÍûºÍÉú³¤Ç÷ÊÆ£¬£¬ £¬£¬ £¬£¬£¬£¬Í¬Ê±ÃæÏòÈ«ÇòÀ¿²Å£¬£¬ £¬£¬ £¬£¬£¬£¬×·ÇóÏàÖúʱ»ú£¬£¬ £¬£¬ £¬£¬£¬£¬½«ÉúÎïÒ©×ö´ó×öÇ¿£¬£¬ £¬£¬ £¬£¬£¬£¬°ÑÑï×Ó½­Ò©Òµ´òÔì³É¾ßÓйú¼Ê¾ºÕùÁ¦µÄÒ»Á÷ÖÆÒ©ÆóÒµ¡£¡£¡£¡£¡£¡£
    ÖпÆÔºÕÔ¹úÆÁԺʿ¡¢Ó¢¹ú¹ú¼ÒҽѧÑо¿Ôº¿Æ¼¼²¿×ܲÃDave Tapolczay¡¢ÃÀ¹úÄϼÓÖÝÉúÎïЭ»á×ܲÃJoseph PanettaµÈÁùλÀ´×Ôº£ÄÚÍâµÄÉúÎïÒ½Ò©ÁìÓòµÄר¼Ò¾ÍÉúÎïÖÆÒ©Éú³¤Ç÷ÊÆÓëÐÂÒ©Ñз¢ÏȺó×öÁËѧÊõÑݽ²£¬£¬ £¬£¬ £¬£¬£¬£¬²¢Óë»áÕß¾ÙÐÐÁËÆÕ±éµÄ½»Á÷ºÍÌÖÂÛ¡£¡£¡£¡£¡£¡£×¨¼ÒÃÇ»¹¾ÍÑï×Ó½­Ò©Òµ¼¯ÍÅÉúÎïÖÆ¼ÁµÄÑз¢¾ÙÐÐÁËרÌâ×êÑС£¡£¡£¡£¡£¡£»£»£»£»£»£»áÉÏ£¬£¬ £¬£¬ £¬£¬£¬£¬¶ÔÂѰ×Ò©Îï¡¢¶àëÄÒ©ÎС·Ö×ÓDNA¡¢ÊÜÌå°ÐÏò¶àëÄÒ©ÎïµÈ9¸öÏàÖúÑз¢ÏîÄ¿¾ÙÐÐÁË̽ÌÖ¡£¡£¡£¡£¡£¡£
    ½ñÄêÊÇÑï×Ó½­Ò©Òµ¼¯Íލ³§40ÖÜÄê¡£¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯Íųм̡°ÇóË÷½øÈ¡¡¢»¤ÓÓÖÚÉú¡±µÄÆóÒµÀíÄ£¬ £¬£¬ £¬£¬£¬£¬¸ß¾Ù¡°Á¢ÒìΪÃñ¡¢¸ßÖÊ»ÝÃñ¡±µÄ´óÆì£¬£¬ £¬£¬ £¬£¬£¬£¬ÖÂÁ¦ÓÚÖгÉÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©µÄÁ¢ÒìÑз¢£¬£¬ £¬£¬ £¬£¬£¬£¬×ۺϾ­¼ÃÐ§ÒæÒÑÒ»Á¬10¶àÄêõÒÉíÌìÏÂҽҩǰÎåÇ¿¡£¡£¡£¡£¡£¡£½üÄêÀ´£¬£¬ £¬£¬ £¬£¬£¬£¬Ñï×Ó½­Ò©Òµ¼¯ÍżӴóÁË×ÔÖ÷֪ʶ²úȨÐÂÒ©µÄÑз¢£¬£¬ £¬£¬ £¬£¬£¬£¬30¶àÃûº£ÄÚÍⲩʿÁìÏÎÑï×Ó½­ÐÂÒ©Ñо¿ÔºµÄÊÂÇ飬£¬ £¬£¬ £¬£¬£¬£¬ÆóÒµ½¨ÉèÁËÖÐÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©ÒÔ¼°Ò©ÎïÖÆ¼ÁÐÂÊÖÒÕ¹ú¼ÒÖØµãʵÑéÊÒµÈÑз¢Æ½Ì¨¡£¡£¡£¡£¡£¡£½èÖú¹ú¼Ò¼¶ÆóÒµÊÖÒÕÖÐÐÄ¡¢²©Ê¿ºó¿ÆÑÐÊÂÇéÕ¾¡¢ÔºÊ¿ÊÂÇéÕ¾¡¢ÖÐÒ©ÖÆÒ©¹¤ÒÕÊÖÒÕ¹ú¼Ò¹¤³ÌÑо¿ÖÐÐĵÈÁ¢ÒìÆ½Ì¨£¬£¬ £¬£¬ £¬£¬£¬£¬Ñï×Ó½­Ò©Òµ¿ÆÑÐЧ¹ûÒ»Ö±Ó¿ÏÖ¡£¡£¡£¡£¡£¡£Ê®Ò»Îåʱ´ú£¬£¬ £¬£¬ £¬£¬£¬£¬Ñï×Ó½­Ò©ÒµÒÑÀÛ¼ÆÍê³ÉÖÖÖÖÐÂÒ©Á¢Ïî65Ï£¬ £¬£¬ £¬£¬£¬£¬ÆäÖÐÁ¢ÒìÒ©Îï26Ï£¬ £¬£¬ £¬£¬£¬£¬ÉêÇë·¢Ã÷רÀû56Ï£¬ £¬£¬ £¬£¬£¬£¬»ñÊÚȨ·¢Ã÷רÀû18Ï£¬ £¬£¬ £¬£¬£¬£¬¹ú¼Ê·¢Ã÷רÀû8¼þ£¬£¬ £¬£¬ £¬£¬£¬£¬Öƶ©¶à¸ö²úÆ·µÄÐÐÒµ±ê×¼44Ï£¬ £¬£¬ £¬£¬£¬£¬Ñо¿Ôº×ª»¯Ð²úƷЧ¹û27Ï£¬ £¬£¬ £¬£¬£¬£¬Ð²úÆ·ÏúÊÛÕ¼¼¯ÍÅÏúÊ۵ıÈÖØÉÏÉýµ½50%¡£¡£¡£¡£¡£¡£Ñо¿Ôº·õ»¯µÄÃ÷ÐDzúÆ·¾­Ç°Æ½¿ÅÁ£»£»£»£»£»£»ñµÃ¹ú¼Ò¿Æ¼¼Ç°½ø¶þµÈ½±¡¢ÖлªÖÐҽҩѧ»áÒ»µÈ½±¡¢¹ú¼Ò·¢Ã÷רÀûÓÅÒì½±¡£¡£¡£¡£¡£¡£¶À¼ÒÆ·ÖÖ°ÙÀÖÃß½ºÄÒ»ñ¹ú¼Ò·¢Ã÷רÀûÌØÊâ½ð½±¡£¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯Íű»¹ú¼Ò¿Æ¼¼²¿¡¢¹ú×Êί¡¢ÖлªÌìÏÂ×ܹ¤»áÊÚÓè¹ú¼ÒÊ×Åú¡°Á¢ÒìÐÍÆóÒµ¡±¡£¡£¡£¡£¡£¡£
http://www.cnpharma.net/?action-viewnews-itemid-2667